[Treatment of osteoarthritis with COX-2 inhibitors: good for the stomach, but bad for the patient?]

Comparative Study

. 2002 Aug 12;164(33):3874-5.

[Article in Danish]

Comparative Study

[Article in Danish]

Stig Ejdrup Andersen. Ugeskr Laeger. 2002.

. 2002 Aug 12;164(33):3874-5.

No abstract available

Comment on

Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
Jüni P, Rutjes AW, Dieppe PA. Jüni P, et al. BMJ. 2002 Jun 1;324(7349):1287-8. doi: 10.1136/bmj.324.7349.1287. BMJ. 2002. PMID: 12039807 Free PMC article. No abstract available.

[Osteoarthritis].
Unkerskov J, Glintborg D, Bach KF, Kampmann JP. Unkerskov J, et al. Ugeskr Laeger. 2002 Aug 12;164(33):3875; author reply 3875-6. Ugeskr Laeger. 2002. PMID: 12216164 Danish. No abstract available.
A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN, Callaghan R, Allen ME, Rowe IF. Price-Forbes AN, et al. Rheumatology (Oxford). 2005 Jul;44(7):921-4. doi: 10.1093/rheumatology/keh642. Epub 2005 Apr 12. Rheumatology (Oxford). 2005. PMID: 15827035
[Osteoarthritis and COX-2 inhibitors].
Lindberg M. Lindberg M. Ugeskr Laeger. 2002 Aug 12;164(33):3874. Ugeskr Laeger. 2002. PMID: 12216162 Danish. No abstract available.
Osteoarthritis therapy--are there still unmet needs?
Laufer S. Laufer S. Rheumatology (Oxford). 2004 Feb;43 Suppl 1:i9-15. doi: 10.1093/rheumatology/keh103. Rheumatology (Oxford). 2004. PMID: 14752170 Review.
Safety of anti-inflammatory treatment--new ways of thinking.
Brune K. Brune K. Rheumatology (Oxford). 2004 Feb;43 Suppl 1:i16-20. doi: 10.1093/rheumatology/keh104. Rheumatology (Oxford). 2004. PMID: 14752171 Review.